Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 142,489 $ 155,714
Equity method investments 2,249,684 1,869,712
Receivables 2,061,000  
Receivables held-for-sale 16,603 85,254
Real estate 352,227 353,000
Investments 10,499 10,200
Securitization assets 193,378 177,032
Other assets 114,229 119,242
Total Assets 5,139,870 4,760,148
Liabilities:    
Accounts payable, accrued expenses and other 120,968 120,114
Credit facilities 358,728 50,698
Commercial paper notes 99,899 192
Term loan facility 380,102 379,742
Senior unsecured notes 1,779,749 1,767,647
Convertible notes 346,607 344,253
Total Liabilities 3,481,055 3,095,402
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 91,657,822 and 90,837,008 shares issued and outstanding, respectively 917 908
Additional paid in capital 1,946,904 1,924,200
Accumulated deficit (297,708) (285,474)
Accumulated other comprehensive income (loss) (32,820) (10,397)
Non-controlling interest 41,522 35,509
Total Stockholders’ Equity 1,658,815 1,664,746
Total Liabilities and Stockholders’ Equity 5,139,870 4,760,148
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $602 million and $632 million, respectively) 395,002 432,756
Commercial receivables    
Assets    
Receivables 1,962,793 1,887,483
Government receivables    
Assets    
Receivables $ 97,968 $ 102,511